(IN BRIEF) TotalEnergies has successfully renewed the production license for OML130 block in Nigeria for an additional 20 years. The block, located off the Nigerian coast, is home to the productive Akpo and Egina fields. In 2022, the block produced … Read the full press release
(PRESS RELEASE) PARIS, 17-Jan-2022 — /EuropaWire/ — TotalEnergies (EPA: TTE), one of the seven “supermajor” oil companies, has announced the divestment of its holdings in Angola Block 14 B.V., held nearly equally with Inpex Angola Block 14 Ltd. The buyer … Read the full press release
(PRESS RELEASE) LUANDA, Angola, 3-Dec-2021 — /EuropaWire/ — TotalEnergies (EPA: TTE), one of the seven “supermajor” oil companies, has announced the start of the production of CLOV Phase 2 off the Angolan coast, a project connected to the existing CLOV … Read the full press release
Posted in Energy, Gas & Oil, France, Industrial, News
Tagged Angola, ANPG, Belarmino Chitangueleca, Block 17, BP Exploration Angola Ltd, CLOV, CLOV FPSO, CLOV Phase 2, Dalia, Equinor, exploration, ExxonMobil, Girassol, Henri-Max Ndong-Nzue, oil, Pazflor, Sonangol P&P, TotalEnergies, Zinia Phase 2
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
